Investors & Media
Publications
2023
-
- September 19, 2023
-
Anokion Publishes Article in Nature Biomedical Engineering Further Validating its Immune Tolerance Approach to Treating Celiac Disease and Multiple Sclerosis
READ MORE
-
- June 15, 2023
-
Article Published in The Lancet Gastroenterology & Hepatology Highlighting Safety and Preliminary Effects of KAN-101 in Celiac Disease in its ACeD Phase 1 Clinical Trial
Read More